Comprehensive identification of mRNA isoforms reveals the diversity of neural cell-surface molecules with roles in retinal development and disease.
Thomas A RayKelly CochranChristopher KozlowskiJingjing WangGraham AlexanderMartha A CadyWilliam J SpencerPhilip A RuzyckiBrian S ClarkAnnelies LaeremansMing-Xiao HeXiaoming WangEmily ParkYing HaoAlessandro IannacconeGary HuOlivier FedrigoNikolai P SkibaVadim Y ArshavskyJeremy N KayPublished in: Nature communications (2020)
Genes encoding cell-surface proteins control nervous system development and are implicated in neurological disorders. These genes produce alternative mRNA isoforms which remain poorly characterized, impeding understanding of how disease-associated mutations cause pathology. Here we introduce a strategy to define complete portfolios of full-length isoforms encoded by individual genes. Applying this approach to neural cell-surface molecules, we identify thousands of unannotated isoforms expressed in retina and brain. By mass spectrometry we confirm expression of newly-discovered proteins on the cell surface in vivo. Remarkably, we discover that the major isoform of a retinal degeneration gene, CRB1, was previously overlooked. This CRB1 isoform is the only one expressed by photoreceptors, the affected cells in CRB1 disease. Using mouse mutants, we identify a function for this isoform at photoreceptor-glial junctions and demonstrate that loss of this isoform accelerates photoreceptor death. Therefore, our isoform identification strategy enables discovery of new gene functions relevant to disease.
Keyphrases
- cell surface
- genome wide
- bioinformatics analysis
- genome wide identification
- mass spectrometry
- optical coherence tomography
- binding protein
- poor prognosis
- copy number
- dna methylation
- brain injury
- cell death
- signaling pathway
- high resolution
- high throughput
- single molecule
- liquid chromatography
- cerebral ischemia
- ms ms
- neuropathic pain